Screener
Asset Entities ASST Medical Device — Income tax expense (benefit)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | Successor / Three Months Ended June 30, 2026 | Predecessor / Three Months Ended June 30, 2025 |
|---|---|---|
| Transaction costs | — | (5,437) |
| Total other income/(expense) | 646 | (5,185) |
| Net loss before income taxes | (257,603) | (8,875) |
| Income tax benefit/(expense) | — | — |
| Net loss | $(257,603) | $(8,875) |
| Dividends on preferred stock | (26,209) | — |
| Net loss attributable to common stockholders | $(283,812) | $(8,875) |
| Weighted average number of common shares outstanding: |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — income tax expense (benefit)?
- Asset Entities (ASST) reported medical device — income tax expense (benefit) of $0 in Q2 2026.
- What does medical device — income tax expense (benefit) mean?
- Reflects the total tax impact, whether an expense or a benefit, attributable to the medical device segment's earnings. Understanding this figure is crucial for calculating the segment's effective tax rate and its contribution to the company's net income.
Ask your AI about Asset Entities's medical device — income tax expense (benefit).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude